Nitrooxidoreductase Rv2466c-Dependent Fluorescent Probe for Mycobacterium tuberculosis Diagnosis and Drug Susceptibility Testing.
Ran MuChengcheng KongWenjun YuHongyao WangYao MaXueyuan LiJie WuSelin Somersan KarakayaHaitao LiZhaogang SunGang LiuPublished in: ACS infectious diseases (2019)
Firstly, this study demonstrated that natural product-inspired coumarin-based nitrofuranyl calanolides (NFCs) can form the Rv2466c-mycothiol (MSH)-NFC (RvMN) ternary complex via NFC binding to W21, N51, and Y61 of Rv2466c and be specifically reduced by Rv2466c, which is accompanied by the generation of a high level of fluorescence. Additionally, the results unveiled that the acetylated cysteine-glucosamine (AcCys-GlcN) motif of MSH is sufficient to interact with Rv2466c and adopt the active conformation that is essential for fully reducing NFCs. Further clinical translational investigation in this Article indicated that the novel fluorescent NFC probe can serve as a much needed high-throughput and low-cost detection method for detection of living Mycobacterium tuberculosis ( Mtb) and can precisely determine MIC values for a full range of available drugs. This method can greatly facilitate the development of phenotypic drug-susceptibility testing (pDST) that will allow the point-of-care treatment of tuberculosis (TB) within a week after diagnosis.
Keyphrases
- mycobacterium tuberculosis
- fluorescent probe
- living cells
- pulmonary tuberculosis
- low cost
- high throughput
- single molecule
- label free
- loop mediated isothermal amplification
- quantum dots
- clinical trial
- emergency department
- single cell
- molecular dynamics simulations
- hepatitis c virus
- gold nanoparticles
- human immunodeficiency virus
- combination therapy